|
|
|
|
Get an in-depth look at the critical aspects of quality assurance for IVT-mRNA based biotherapeutics solutions that focus on enhancing fidelity in throughput, innovative technologies, and methodologies to optimize your RNA research and development.
|
|
|
|
|
Read about how Kaneka Eurogentec, a leading provider of custom DNA synthesis and molecular biology services, enhanced their fragment analysis to achieve higher efficiency and accuracy in their workflows with an innovative Fragment Analyzer System.
|
|
|
|
|
Uncover new innovative solutions for mRNA analysis to enhance accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.
|
|
|
|
|
In vitro transcribed mRNA revolutionizes biotherapeutics, which necessitates thorough quality assessments. Gain insight into how an analyzer system enhances encapsulation efficiency and critical quality attributes in IVT mRNA workflows.
|
|
|
|
|
Various regulatory agencies have issued guidelines concerning the Critical Quality Attributes (CQAs) of IVT mRNA in vaccines and other biotherapeutic applications. Learn more about these issued guidelines on CQAs to focus on drug substance and LNP-encapsulated drug product assessment using an analyzer system.
|
|
|
|
|
|
|
Watch how to prepare samples, instruments, and software for a system that streamlines the analysis of up to 96 samples simultaneously to enhance lab efficiency and throughput.
|
|
|
